These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 11497350)
1. Antisense oligonucleotides strategy in the treatment of hypertension. Kagiyama S; Kagiyama T; Phillips MI Curr Opin Mol Ther; 2001 Jun; 3(3):258-64. PubMed ID: 11497350 [TBL] [Abstract][Full Text] [Related]
2. Antisense therapeutics for hypertension: targeting the renin-angiotensin system. Phillips MI; Kimura B Methods Mol Med; 2005; 106():51-68. PubMed ID: 15375312 [No Abstract] [Full Text] [Related]
3. Angiotensin-converting enzyme 2 as a novel target for gene therapy for hypertension. Katovich MJ; Grobe JL; Huentelman M; Raizada MK Exp Physiol; 2005 May; 90(3):299-305. PubMed ID: 15640278 [TBL] [Abstract][Full Text] [Related]
4. Gene-based therapy for hypertension--do preclinical data suggest a promising future? Puddu GM; Cravero E; Ferrari E; Muscari A; Puddu P Cardiology; 2007; 108(1):40-7. PubMed ID: 16968989 [TBL] [Abstract][Full Text] [Related]
5. Not nonsense but antisense--applications of antisense oligonucleotides in different fields of medicine. Oberbauer R Wien Klin Wochenschr; 1997 Jan; 109(2):40-6. PubMed ID: 9123943 [TBL] [Abstract][Full Text] [Related]
6. Antisense therapy in malignant diseases: status quo and quo vadis? Tamm I Clin Sci (Lond); 2006 Apr; 110(4):427-42. PubMed ID: 16526947 [TBL] [Abstract][Full Text] [Related]
7. Construction of a bispecific antisense oligonucleotide containing multiple binding sites for the treatment of hormone insensitive prostate tumors. Rubenstein M; Tsui P; Guinan P Med Hypotheses; 2005; 65(5):905-7. PubMed ID: 16023790 [TBL] [Abstract][Full Text] [Related]
8. Treatment of malignant gliomas with TGF-beta2 antisense oligonucleotides. Hau P; Jachimczak P; Bogdahn U Expert Rev Anticancer Ther; 2009 Nov; 9(11):1663-74. PubMed ID: 19895249 [TBL] [Abstract][Full Text] [Related]
9. [Gene therapy of hypertension]. Wang ZG; Wen SJ; Wu ZS Sheng Li Ke Xue Jin Zhan; 2001 Oct; 32(4):312-7. PubMed ID: 12545857 [TBL] [Abstract][Full Text] [Related]
10. [Applications of antisense oligonucleotides in oncology]. Pierga JY; Cammilleri S; Benyahia B; Magdelénat H Bull Cancer; 1994 Dec; 81(12):1023-42. PubMed ID: 7742591 [TBL] [Abstract][Full Text] [Related]
11. The future of antihypertensive treatment. Israili ZH; Hernández-Hernández R; Valasco M Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579 [TBL] [Abstract][Full Text] [Related]
12. Targeted therapy of human laryngeal squamous cell carcinoma in vitro by antisense oligonucleotides directed against telomerase reverse transcriptase mRNA. Tao Z; Chen S; Wu Z; Xiao B; Liu J; Hou W J Laryngol Otol; 2005 Feb; 119(2):92-6. PubMed ID: 15829059 [TBL] [Abstract][Full Text] [Related]
13. Antisense inhibition of hypertension: a new strategy for renin-angiotensin candidate genes. Phillips MI; Wielbo D; Gyurko R Kidney Int; 1994 Dec; 46(6):1554-6. PubMed ID: 7700004 [TBL] [Abstract][Full Text] [Related]
14. Perspectives on antisense therapy for the prevention of restenosis. Kipshidze N; Moses J; Shankar LR; Leon M Curr Opin Mol Ther; 2001 Jun; 3(3):265-77. PubMed ID: 11497351 [TBL] [Abstract][Full Text] [Related]
16. G3139 induces cell death by caspase-dependent and -independent apoptosis on human melanoma cell lines. Nakamura S; Inui M; Kamei T; Nakase M; Okumura K; Tagawa T Oncol Rep; 2006 Jun; 15(6):1563-8. PubMed ID: 16685396 [TBL] [Abstract][Full Text] [Related]
17. The potential role of antisense oligodeoxynucleotide therapy for cardiovascular disease. Phillips MI; Galli SM; Mehta JL Drugs; 2000 Aug; 60(2):239-48. PubMed ID: 10983731 [TBL] [Abstract][Full Text] [Related]
18. The zebrafish as a novel system for functional genomics and therapeutic development applications. Nasevicius A; Ekker SC Curr Opin Mol Ther; 2001 Jun; 3(3):224-8. PubMed ID: 11497344 [TBL] [Abstract][Full Text] [Related]